CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Viewray Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Viewray Inc
2 Thermo Fisher Way
Phone: (440) 703-3210p:440 703-3210 Oakwood Village, OH  44146-6536  United States Ticker: VRAYQVRAYQ
Filed for Bankruptcy on 7/16/2023
Case #23-10935, filed in the U.S. Bankruptcy Court for the District of Delaware
On 10/26/2023, the voluntary petition for the Company for reorganization under Chapter 11 was converted to Chapter 7
Business Summary
ViewRay, Inc. is engaged in designing, manufacturing, and marketing the MRIdian MRI-Guided Radiation Therapy System. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumors from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The Company has installed approximately 56 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202312/31/2022YesYesYes--

Industries
SIC Code Description
3844 X-ray apparatus and tubes and related irradiation apparatus
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Daniel J.Moore 62 2/1/2018 2/1/2018
President, Chief Executive Officer PaulZiegler 51 7/15/2023 7/1/2021
Interim Chief Financial Officer CassieMahar 37 7/15/2023 7/15/2023
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ViewRay Technologies, Inc. 1099 18th Street Denver CO United States

Business Names
Business Name
Mirax Corp
ViewRay GmbH
ViewRay Incorporated
VRAY
VRAYQ
X-VRAY

General Information
Number of Employees: 295 (As of 12/31/2022)
Outstanding Shares: 183,402,038 (As of 4/28/2023)
Shareholders: 71
Stock Exchange: OTC
Federal Tax Id: 200818429


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 6, 2024